Unconfigured Ad

Collapse

Application of sequencing to RNA analysis (RNA-Seq, whole transcriptome, SAGE, expression analysis, novel organism mining, splice variants)

Forums Topics Posts Last Post
No forums found.
  •  
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by jgoecks, 11-29-2010, 02:06 PM
27 responses
76,078 views
0 reactions
Last Post suparmin  
Started by wynstep, 08-10-2014, 03:25 AM
8 responses
5,169 views
0 reactions
Last Post kerplunk412  
Started by francisb, 08-28-2014, 02:53 AM
4 responses
2,852 views
0 reactions
Last Post khughitt  
Started by hchang10, 08-22-2014, 12:27 PM
1 response
2,329 views
0 reactions
Last Post Gordon Smyth  
Started by vaibhav_jain, 01-21-2013, 02:51 AM
7 responses
5,050 views
0 reactions
Last Post krespim
by krespim
 
Started by sibelletorres, 08-26-2014, 08:59 AM
0 responses
2,648 views
0 reactions
Last Post sibelletorres  
Started by manasarai2009, 08-26-2014, 03:47 AM
1 response
3,145 views
0 reactions
Last Post Richard Finney  
Started by bioman1, 08-25-2014, 01:39 AM
4 responses
4,697 views
0 reactions
Last Post mbblack
by mbblack
 
Started by sterding, 11-11-2013, 08:55 AM
2 responses
3,830 views
0 reactions
Last Post sterding  
Started by michael.sharpnack, 08-21-2014, 10:52 AM
1 response
2,982 views
0 reactions
Last Post shi
by shi
 
Started by super0925, 08-19-2014, 07:54 AM
6 responses
2,675 views
0 reactions
Last Post super0925  
No topics found.
  • Time
Clear All
No photos found.
  • Time
Clear All

Webinars

Collapse

Recent Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Working...